Shanelle De Lancy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shanelle De Lancy has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Amanda M. Ackermann
Division of Endocrinology and Diabetes, The Children’s Hospital of Philadelphia, Philadelphia, PA
1 shared publication - Boaz Karmazyn
Department of Radiology and Imaging Sciences Indiana University School of Medicine, Riley Hospital for Children at IU Health Indianapolis Indiana USA
1 shared publication Demitrios Dedousis
Department of Genetics and Genome Sciences and Center for Human Genetics, University Hospitals Cleveland Medical Center/Rainbow Babies and Children’s Hospital, Case Western University School of Medicine, Cleveland, OH, USA
1 shared publicationDenise D Young
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University Hospitals Cleveland Medical Center/Rainbow Babies and Children’s Hospital, Case Western University School of Medicine, Cleveland, OH, USA
1 shared publication- Diane W. Chen
Department of Otolaryngology–Head and Neck Surgery Indiana University School of Medicine Indianapolis Indiana USA
1 shared publication Edwin C Ferren
Department of Genetics and Genome Sciences and Center for Human Genetics, University Hospitals Cleveland Medical Center/Rainbow Babies and Children’s Hospital, Case Western University School of Medicine, Cleveland, OH, USA
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Wiley in Journal of Clinical Ultrasound
Contrast‐Enhanced Ultrasound in the Diagnosis of Parotid Gland Castleman Disease in a Child
Castleman disease is a rare lymphoproliferative disorder that infrequently involves the parotid gland. We report a 16‐year‐old girl with a 3‐year history of slowly progressive, painless right cheek swelling. CT and MRI showed an avidly enhancing, markedly T2‐hyperintense parotid lesion, suggesting a vascular malformation; fine‐needle aspiration yielded reactive lymphoid tissue. Contrast‐enhanced ultrasound (CEUS) demonstrated rapid, intense, homogeneous enhancement, confirming a hypervascular solid mass rather than a vascular malformation and raising suspicion for Castleman disease. Superficial parotidectomy confirmed unicentric hyaline‐vascular Castleman disease. CEUS aided differentiation of a hypervascular solid lesion from a vascular malformation and narrowed the differential.
- 20 October 2026
- Published by Wiley in Journal of Clinical Ultrasound
Open AccessContrast‐Enhanced Ultrasound in the Diagnosis of Parotid Gland Castleman Disease in a Child
Castleman disease is a rare lymphoproliferative disorder that infrequently involves the parotid gland. We report a 16‐year‐old girl with a 3‐year history of slowly progressive, painless right cheek swelling. CT and MRI showed an avidly enhancing, markedly T2‐hyperintense parotid lesion, suggesting a vascular malformation; fine‐needle aspiration yielded reactive lymphoid tissue. Contrast‐enhanced ultrasound (CEUS) demonstrated rapid, intense, homogeneous enhancement, confirming a hypervascular solid mass rather than a vascular malformation and raising suspicion for Castleman disease. Superficial parotidectomy confirmed unicentric hyaline‐vascular Castleman disease. CEUS aided differentiation of a hypervascular solid lesion from a vascular malformation and narrowed the differential.
- Open Access
- 24 November 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (21) , 2305
Metastatic carcinoma mimicking hemophagocytic lymphohistiocytosis
- 24 November 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (21) , 2305
Open AccessMetastatic carcinoma mimicking hemophagocytic lymphohistiocytosis
- Open Access
- 2 January 2021
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 5 (2) , bvaa196
A Novel Homozygous Missense Mutation in the YARS Gene: Expanding the Phenotype of YARS Multisystem Disease
Aminoacyl-tRNA synthetases (ARSs) are crucial enzymes for protein translation. Mutations in genes encoding ARSs are associated with human disease. Tyrosyl-tRNA synthetase is encoded by YARS which is ubiquitously expressed and implicated in an autosomal dominant form of Charcot-Marie-Tooth and autosomal recessive YARS-related multisystem disease. We report on a former 34-week gestational age male who presented at 2 months of age with failure to thrive (FTT) and cholestatic hepatitis. He was subsequently diagnosed with hyperinsulinemic hypoglycemia with a negative congenital hyperinsulinism gene panel and F-DOPA positron-emission tomography (PET) scan that did not demonstrate a focal lesion. Autopsy findings were notable for overall normal pancreatic islet size and morphology. Trio whole exome sequencing identified a novel homozygous variant of uncertain significance in YARS (c.611A > C, p.Tyr204Cys) with each parent a carrier for the YARS variant. Euglycemia was maintained with diazoxide (max dose, 18 mg/kg/day), and enteral dextrose via gastrostomy tube (G-Tube). During his prolonged hospitalization, the patient developed progressive liver disease, exocrine pancreatic insufficiency, acute renal failure, recurrent infections, ichthyosis, hematologic concerns, hypotonia, and global developmental delay. Such multisystem features have been previously reported in association with pathogenic YARS mutations. Although hypoglycemia has been associated with pathogenic YARS mutations, this report provides more conclusive data that a YARS variant can cause hyperinsulinemic hypoglycemia. This case expands the allelic and clinical heterogeneity of YARS-related disease. In addition, YARS-related disease should be considered in the differential of hyperinsulinemic hypoglycemia associated with multisystem disease.
- 2 January 2021
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 5 (2) , bvaa196
Open AccessA Novel Homozygous Missense Mutation in the YARS Gene: Expanding the Phenotype of YARS Multisystem Disease
Aminoacyl-tRNA synthetases (ARSs) are crucial enzymes for protein translation. Mutations in genes encoding ARSs are associated with human disease. Tyrosyl-tRNA synthetase is encoded by YARS which is ubiquitously expressed and implicated in an autosomal dominant form of Charcot-Marie-Tooth and autosomal recessive YARS-related multisystem disease. We report on a former 34-week gestational age male who presented at 2 months of age with failure to thrive (FTT) and cholestatic hepatitis. He was subsequently diagnosed with hyperinsulinemic hypoglycemia with a negative congenital hyperinsulinism gene panel and F-DOPA positron-emission tomography (PET) scan that did not demonstrate a focal lesion. Autopsy findings were notable for overall normal pancreatic islet size and morphology. Trio whole exome sequencing identified a novel homozygous variant of uncertain significance in YARS (c.611A > C, p.Tyr204Cys) with each parent a carrier for the YARS variant. Euglycemia was maintained with diazoxide (max dose, 18 mg/kg/day), and enteral dextrose via gastrostomy tube (G-Tube). During his prolonged hospitalization, the patient developed progressive liver disease, exocrine pancreatic insufficiency, acute renal failure, recurrent infections, ichthyosis, hematologic concerns, hypotonia, and global developmental delay. Such multisystem features have been previously reported in association with pathogenic YARS mutations. Although hypoglycemia has been associated with pathogenic YARS mutations, this report provides more conclusive data that a YARS variant can cause hyperinsulinemic hypoglycemia. This case expands the allelic and clinical heterogeneity of YARS-related disease. In addition, YARS-related disease should be considered in the differential of hyperinsulinemic hypoglycemia associated with multisystem disease.